Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
5.17
-0.06 (-1.15%)
At close: Apr 28, 2026, 4:00 PM EDT
5.15
-0.02 (-0.39%)
After-hours: Apr 28, 2026, 6:57 PM EDT
Intensity Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 11.92 | 2.59 | 8.56 | 1.31 | 4.54 | |
| Short-Term Investments | - | - | 6.22 | - | - | |
| Cash & Short-Term Investments | 11.92 | 2.59 | 14.78 | 1.31 | 4.54 | |
| Cash Growth | 360.27% | -82.47% | 1026.22% | -71.10% | -51.28% | |
| Other Receivables | - | - | - | - | 0.05 | |
| Receivables | - | - | - | - | 0.05 | |
| Prepaid Expenses | 0.79 | 0.77 | 0.69 | 0.06 | 0.07 | |
| Other Current Assets | - | - | - | 0.08 | 0.07 | |
| Total Current Assets | 12.71 | 3.36 | 15.46 | 1.45 | 4.73 | |
| Property, Plant & Equipment | 0.1 | 0.12 | 0.15 | 0.14 | 0.32 | |
| Other Long-Term Assets | 1.3 | 1.3 | 1.68 | 0.17 | 0.17 | |
| Accounts Payable | 0.58 | 1.22 | 3.05 | 0.6 | 0.17 | |
| Accrued Expenses | 1.53 | 0.51 | 0.89 | 0.33 | 0.34 | |
| Short-Term Debt | - | - | - | 4.35 | 2.02 | |
| Current Portion of Leases | 0.03 | 0.03 | 0.02 | 0.14 | 0.18 | |
| Other Current Liabilities | - | - | - | 1.39 | 1.01 | |
| Total Current Liabilities | 2.15 | 1.76 | 3.96 | 6.82 | 3.72 | |
| Long-Term Leases | 0.08 | 0.11 | 0.14 | - | 0.14 | |
| Other Long-Term Liabilities | - | - | 0.04 | 0.04 | 0.04 | |
| Common Stock | - | - | 0 | - | 0 | |
| Additional Paid-In Capital | 90.27 | 69.7 | 63.68 | 23.56 | 22.39 | |
| Retained Earnings | -78.39 | -66.78 | -50.52 | -38.65 | -31.07 | |
| Total Common Equity | 11.88 | 2.92 | 13.16 | -15.1 | -8.68 | |
| Total Liabilities & Equity | 14.1 | 4.78 | 17.3 | 1.76 | 5.22 | |
| Total Debt | 0.11 | 0.14 | 0.16 | 4.49 | 2.34 | |
| Net Cash (Debt) | 11.81 | 2.45 | 14.62 | -3.18 | 2.2 | |
| Net Cash Growth | 381.69% | -83.23% | - | - | -75.09% | |
| Net Cash Per Share | 8.71 | 4.41 | 42.41 | -23.31 | 16.10 | |
| Filing Date Shares Outstanding | 2.54 | 0.61 | 0.55 | 0.14 | 0.14 | |
| Total Common Shares Outstanding | 2.52 | 0.6 | 0.55 | 0.14 | 0.14 | |
| Working Capital | 10.56 | 1.61 | 11.51 | -5.37 | 1.01 | |
| Book Value Per Share | 4.70 | 4.82 | 24.00 | -110.69 | -63.67 | |
| Tangible Book Value | 11.88 | 2.92 | 13.16 | -15.1 | -8.68 | |
| Tangible Book Value Per Share | 4.70 | 4.82 | 24.00 | -110.69 | -63.67 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.